Development Assistance for COVID-19 Vaccine Delivery 2020-2021
GHDx Entry last modified on: Mar 16, 2023
COVID-19
Dataset Records for COVID-19
Displaying 1401 - 1450 of 1560
Development Assistance for COVID-19 Vaccine Delivery 2020-2021
SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study
GHDx Entry last modified on: Mar 8, 2024
The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy
GHDx Entry last modified on: Mar 22, 2024
Prevalence and Associated Factors of Post-COVID-19 Syndrome in a Brazilian Cohort after 3 and 6 Months of Hospital Discharge
GHDx Entry last modified on: Mar 22, 2024
Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort
GHDx Entry last modified on: Mar 22, 2024
Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster?
GHDx Entry last modified on: Oct 23, 2024
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations
GHDx Entry last modified on: Feb 1, 2024
SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia
GHDx Entry last modified on: Mar 14, 2022
Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing. Preprint
GHDx Entry last modified on: Mar 14, 2022
Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study
GHDx Entry last modified on: Jan 31, 2024
Outcomes and implications of diarrhea in patients with SARS-CoV-2 infection
GHDx Entry last modified on: Mar 14, 2022
Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study
GHDx Entry last modified on: Mar 14, 2022
Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid
GHDx Entry last modified on: Mar 14, 2022
A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled blood. Preprint
GHDx Entry last modified on: Mar 14, 2022
The seroprevalence and trends of SARS-CoV-2 in Delhi, India: A repeated population-based seroepidemiological study. Preprint
GHDx Entry last modified on: May 12, 2022
Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study
GHDx Entry last modified on: Dec 19, 2023
Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia
GHDx Entry last modified on: Jun 17, 2021
How to prevent in-hospital COVID-19 infection and reassure women about the safety of pregnancy: Experience from an obstetric center in China
GHDx Entry last modified on: Jan 31, 2024
[Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation]
ОСОБЕННОСТИ ФОРМИРОВАНИЯ СЕРОПРЕВАЛЕНТНОСТИ НАСЕЛЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ К НУКЛЕОКАПСИДУ SARS-CoV-2 В ПЕРВУЮ ВОЛНУ ЭПИДЕМИИ COVID-19
Pregnancy affected by SARS-CoV-2 infection: a flash report from Michigan
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020
GHDx Entry last modified on: May 12, 2022
Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 of IgG antibody by ELISA: Community-based, cross-sectional study from urban area of Malegaon, Maharashtra
GHDx Entry last modified on: Jan 31, 2024
Ninety days post-hospitalization evaluation of residual COVID-19 symptoms through a phone call check list
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020<sup>1</sup>
GHDx Entry last modified on: May 12, 2022
Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey
GHDx Entry last modified on: Jan 31, 2024
Late incidence of SARS-CoV-2 infection in a highly-endemic remote rural village. A prospective population-based cohort study
GHDx Entry last modified on: Mar 14, 2022
Development Assistance for Health on COVID-19 2020
GHDx Entry last modified on: Oct 20, 2022
Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers
GHDx Entry last modified on: Mar 14, 2022
Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey
GHDx Entry last modified on: Jan 31, 2024
Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021
GHDx Entry last modified on: May 12, 2022
Finland COVID-19 Cases in the Infectious Disease Registry 2020-2022
COVID-19 Cases in the Infectious Disease Registry
Disease registry:
Epi surveillance
Impact of Recommended Maternal Vaccination Programs on the Clinical Presentation of SARS-CoV-2 Infection: A Prospective Observational Study
GHDx Entry last modified on: Apr 10, 2023
Management of pregnant women with COVID-19: A tertiary pandemic center experience on 1416 cases
GHDx Entry last modified on: Apr 10, 2023
Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study
GHDx Entry last modified on: Jan 31, 2024
Spanish registry of Covid-19 screening in asymptomatic pregnants.
GHDx Entry last modified on: Apr 10, 2023
Iraq Annual Statistical Report 2020
التقرير االحصائي السنوي
Report:
Epi surveillance - Inpatient - National vital registration - Nationally representative - Outpatient - Subnationally representative
Rationale, Design, and Characteristics of the VALIANT (COVID-19 in Older Adults: A Longitudinal Assessment) Cohort
GHDx Entry last modified on: Mar 22, 2024
Persistent COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA)
GHDx Entry last modified on: Mar 22, 2024
Risk factors associated with limited functional status among out-of-hospital patients 30days and one year after a diagnosis of COVID-19: a cohort study
GHDx Entry last modified on: Mar 22, 2024
Symptom Burden among Older COVID-19 Survivors Two Years after Hospital Discharge
GHDx Entry last modified on: Mar 22, 2024
COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)
GHDx Entry last modified on: Oct 23, 2024
SARS-CoV-2 Daily and Cumulative Infection Estimates 2019-2021
GHDx Entry last modified on: Jun 15, 2022
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020
Report:
Epi surveillance
United States - Colorado Department of Public Health and Environment COVID19 State-Level Expanded Case Data 2019-2022
CDPHE COVID19 State-Level Expanded Case Data
Social Determinants of Health and Risk of SARS-CoV-2 Infection in Community-Dwelling Older Adults Living in a Rural Latin American Setting
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador
GHDx Entry last modified on: Mar 14, 2022
Subscribe